Pharma Manufacturing
Pharmaceutical contract manufacturing in 2026 evolves as CDMOs become strategic partners driving scale, compliance, and innovation.
Mrudula Kulkarni | Jan 06, 2026
Building KSM Manufacturing Clusters: Opportunities For SMEs In The Pharmaceutical Industry
Vaibhavi M. | Dec 06, 2025
PVC-Free, Recyclable, and Compostable Blister Packs: The Future of Green Pharma Packaging
Ravindra Warang | Jun 23, 2025
Other trending pieces on pharma manufacturing you may like to read
Top 10 Companies Providing mRNA-Based Therapeutics In 2026
Top global companies advancing mRNA therapeutics in 2026, from vaccines to cancer immunotherapy and rare disease treatments.
by Mrudula Kulkarni
Top 10 Pharmaceutical Contract Manufacturing Companies in 2026
Pharmaceutical contract manufacturing in 2026 evolves as CDMOs become strategic partners driving scale, compliance, and innovation.
by Mrudula Kulkarni
Manufacturing mRNA Therapeutics: An Overview
Explore how mRNA therapeutics are manufactured, from DNA templates to LNP formulation, with key challenges, regulations, and future trends.
by Mrudula Kulkarni
Vaccine Contract Manufacturing Market in 2026: Trends, Growth Drivers, and Strategic Outlook
Vaccine contract manufacturing in 2026 shifts toward digitalization, regionalization, and strategic CDMO partnerships powering global immunization
by Mrudula Kulkarni
Water Stewardship in High-risk Zones: Pharma’s Call to Action in 2026
Why water stewardship is critical for pharma manufacturing in 2026 and how it impacts global health, supply chains, and community resilience.
by Thaddeus Anim-Somuah
